Section Arrow
VCYT.NASDAQ
- Veracyte
Quotes are at least 15-min delayed:2025/09/17 17:00 EDT
After Hours
Last
 31.83
0 (0.00%)
Bid
31.04
Ask
35
High 31.83 
Low 31.55 
Volume 39349 
Regular Hours
Last
 31.83
-0.45 (-1.39%)
Day High 
33.02 
Prev. Close
32.28 
1-M High
32.7927 
Volume 
745.37K 
Bid
31.04
Ask
35
Day Low
31.43 
Open
32.4 
1-M Low
28.25 
Market Cap 
2.54B 
Currency USD 
P/E 93.03 
%Yield -- 
10-SMA 31.67 
20-SMA 30.69 
50-SMA 27.86 
52-W High 47.3162 
52-W Low 22.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.34/1.27
Enterprise Value
2.58B
Balance Sheet
Book Value Per Share
15.52
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
445.76M
Operating Revenue Per Share
4.36
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies0.1826-0.0784-30.04%-- 
After Hours 0.1825 -0.0001 -0.05%
NEOGNeogen Corp5.46+0.19+3.61%879PE
After Hours 5.46 0 0.00%
DHRDanaher Corp192.94+2.47+1.30%40.44PE
After Hours 193.31 +0.37 +0.19%
NEONeoGenomics8.11+0.12+1.50%-- 
After Hours 8.06 -0.05 -0.62%
CHEKCheck-Cap Ltd2.32-0.2-7.94%-- 
After Hours 2.37 +0.05 +2.16%
Quotes are at least 15-min delayed:2025/09/17 17:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.